米国における治療抵抗性うつ病に対するサイロシビン補助療法:モデルベースの費用対効果分析
Anton L V Avanceña1,2, Linh Vuong3, James G Kahn4,5,6
1Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA. antonlv@utexas.edu.
Translational psychiatry
|August 29, 2025
まとめ
サイロサイビン補助療法 (PAT) は,治療抵抗性うつ病 (TRD) の場合,費用が5000ドル以下である場合に潜在的な経済的価値を示しています. 長期的な有効性を確認し,PATの費用を削減するには,さらなる研究が必要です.
科学分野:
- 精神科 と 精神 保健
- 健康 経済
- 薬学経済学
背景:
- 重度のうつ病 (MDD) と治療抵抗性 (TRD) は大きな課題となっています.
- サイロシビン補助療法 (PAT) は,TRDの症状を軽減するための初期試験において有望であることが示されています.
- TRDの標準治療 (SOC) には,薬物療法,心理療法,ECT,エスケタミンが含まれています.
研究 の 目的:
- SOCと比較してTRDの第三線治療としてPATの費用対効果を評価する.
- PATの経済的価値を12ヶ月間,医療と社会の観点から分析する.
主な方法:
- 個別レベルの確率的シミュレーションモデルが採用されました.
- このモデルでは,SOCとPATの対比で,TRDを患った米国成人をシミュレートした.
- 主な指標は,総コスト,品質調整された寿命年数 (QALYs),インクリメンタルコスト効率比率 (ICERs) でした.
主要な成果:
- PATは,0.031の追加QALYと,SOCよりも3639ドル高いコストをもたらし,ICERは117,517ドル/QALYとなった.
- $150,000/QALYの値で,PATは費用対効果の75%の確率を持っていた.
- 費用対効果はPATの価格に非常に敏感で,確率95%で3000ドル,1000ドルで1%でした.
結論:
- PATは,総費用が5000ドル以下である場合,TRD治療の経済的価値を提供することができます.
- PATのコスト削減は 費用対効果の向上に不可欠です
- 寛解の維持と再発の予防におけるPATの長期的な有効性については,さらなる調査が必要である.
関連する概念動画
01:30Electroconvulsive Therapy
181
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
181
01:26Psychosis: Goals of Pharmacotherapy
208
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208
01:30Psychosurgery
104
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
104
01:24Treatment Strategies for Psychological Disorders
265
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
265
01:25Interpersonal Psychotherapy
97
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
97
01:23Antidepressant Drugs: MAOIs and Other Agents
337
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
337